Rituximab in practice: Clinical evaluation of patients with pemphigus after rituximab administration-Reference-Cited by-同舟云学术

Rituximab in practice: Clinical evaluation of patients with pemphigus after rituximab administration

Published:2020-12-15 Issue:1 Volume:34 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Mahmoudi Hamidreza¹^ORCID,Tavakolpour Soheil¹²^ORCID,Balighi Kamran¹,Farid Ali Salehi¹^ORCID,Nili Ali¹^ORCID,Jan Delnavaz¹^ORCID,Daneshpazhooh Maryam¹^ORCID

Affiliation:

1. Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences Tehran Iran

2. Dana‐Farber Cancer Institute, Harvard Medical School Boston Massachusetts USA

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14633

Reference50 articles.

1. Pemphigus

2. Pemphigus

3. Single‐nucleotide polymorphisms associated with pemphigus vulgaris: Potent markers for better treatment and personalized medicine

4. Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus

5. Cutaneous type pemphigus vulgaris: A rare clinical phenotype of pemphigus

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the depths of IgG4: insights into autoimmunity and novel treatments;Frontiers in Immunology;2024-04-18

2. Combination therapy for management of pemphigus patients with unexpected therapeutic response to rituximab: A report of five cases;Clinical Case Reports;2023-11

3. Rituximab bij auto-immune blaarziekten;Tijdschrift voor Geneeskunde;2023-10-26

4. Pemphigus Disease and Area Index: Unmet needs in the real‐world management of pemphigus;Oral Diseases;2023-08-21

5. Adverse outcome and severity of COVID ‐19 in patients with autoimmune bullous diseases: A historical cohort study;Dermatologic Therapy;2022-07-21